ReWalk Robotics appoints Joseph Turk to board of directors

Lifeward Ltd.

Board increased to 9 members; Joseph Turk appointed Class I Director effective Apr 20, 2022.
Turk is EVP of Fresenius Medical Care North America & President of its Renal Therapies group.
Previously held leadership roles at NxStage Medical from 2000 to 2019.
Will receive standard non-employee director compensation per prior proxy statement.
No transactions requiring disclosure under Item 404(a); no family relationships with directors or officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph Turk

Class I Director

LFWD · Lifeward Ltd.

Effective: 2022-04-20
Filed: April 20, 2022, 7:59 PM ET

appointed Mr. Joseph Turk as a Class I Director of the Company to serve until the 2024 annual general meeting of shareholders, with such appointment to take effect on April 20, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Turk was appointed as Class I Director at Lifeward Ltd..

Action: appointed
Role: Class I Director

Exact text from the filing

appointed Mr. Joseph Turk as a Class I Director of the Company to serve until the 2024 annual general meeting of shareholders, with such appointment to take effect on April 20, 2022.

View on SEC.gov

Lifeward Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-22-001546

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.